Notice: This company has been marked as potentially delisted and may not be actively trading. SeqLL (SQL) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsInsider TradesTrends SQL vs. BIAFW, PRENW, SQLLW, STRRP, MIND, BNSO, COEP, XWEL, ATHE, and OTRKShould you be buying SeqLL stock or one of its competitors? The main competitors of SeqLL include bioAffinity Technologies (BIAFW), Prenetics Global (PRENW), SeqLL (SQLLW), Star Equity (STRRP), MIND Technology (MIND), Bonso Electronics International (BNSO), Coeptis Therapeutics (COEP), XWELL (XWEL), Alterity Therapeutics (ATHE), and Ontrak (OTRK). SeqLL vs. bioAffinity Technologies Prenetics Global SeqLL Star Equity MIND Technology Bonso Electronics International Coeptis Therapeutics XWELL Alterity Therapeutics Ontrak SeqLL (NASDAQ:SQL) and bioAffinity Technologies (NASDAQ:BIAFW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, community ranking, media sentiment, institutional ownership and valuation. Does the MarketBeat Community favor SQL or BIAFW? SeqLL received 1 more outperform votes than bioAffinity Technologies when rated by MarketBeat users. CompanyUnderperformOutperformSeqLLOutperform Votes1100.00% Underperform VotesNo VotesbioAffinity TechnologiesN/AN/A Do insiders & institutionals have more ownership in SQL or BIAFW? 1.8% of SeqLL shares are held by institutional investors. 22.3% of SeqLL shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer SQL or BIAFW? In the previous week, SeqLL's average media sentiment score of 0.67 beat bioAffinity Technologies' score of 0.00 indicating that SeqLL is being referred to more favorably in the media. Company Overall Sentiment SeqLL Positive bioAffinity Technologies Neutral Which has better valuation and earnings, SQL or BIAFW? bioAffinity Technologies has higher revenue and earnings than SeqLL. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSeqLL$80K24.77-$4.09M-$16.40-0.32bioAffinity Technologies$9.37MN/AN/AN/AN/A Is SQL or BIAFW more profitable? bioAffinity Technologies' return on equity of 0.00% beat SeqLL's return on equity.Company Net Margins Return on Equity Return on Assets SeqLLN/A -124.09% -64.18% bioAffinity Technologies N/A N/A N/A SummarySeqLL beats bioAffinity Technologies on 4 of the 7 factors compared between the two stocks. Ad Darwin2024 Election Year Stocks: Uncover Hidden Gems!In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.Secure your copy now by clicking this link. Get SeqLL News Delivered to You Automatically Sign up to receive the latest news and ratings for SQL and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SQL vs. The Competition Export to ExcelMetricSeqLLDiagnostics & Research IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.98M$26.66M$5.10B$8.84BDividend YieldN/A5.44%5.04%4.07%P/E Ratio-0.321.9195.1214.22Price / Sales24.772,197.391,217.3088.42Price / CashN/A9.9539.4936.27Price / Book0.352.336.976.37Net Income-$4.09M$45.44M$118.73M$225.56M SeqLL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SQLSeqLLN/A$5.20+3.0%N/A+1.2%$1.98M$80,000.00-0.327BIAFWbioAffinity TechnologiesN/A$0.70+12.6%N/A+418.8%$0.00$9.37M0.0010PRENWPrenetics GlobalN/A$0.01-4.0%N/A+0.0%$0.00$22.66M0.001SQLLWSeqLLN/A$0.00flatN/AN/A$0.00$1,177.000.007STRRPStar EquityN/A$9.45+0.6%N/A-0.5%$0.00$50.38M0.00171MINDMIND Technology0.8576 of 5 stars$3.85+1.3%N/A-22.1%$5.43M$36.51M-126.62145BNSOBonso Electronics InternationalN/AN/AN/AN/A$5.44M$14.80M0.00208COEPCoeptis TherapeuticsN/A$0.19-0.9%N/A-83.3%$7.90M$80,000.000.002XWELXWELL1.6551 of 5 stars$1.50+0.7%N/A-25.9%$7.89M$30.11M0.00360Positive NewsATHEAlterity Therapeutics3.1517 of 5 stars$1.08+2.9%$4.00+270.4%N/A$7.88MN/A0.0010Gap UpOTRKOntrak2.7325 of 5 stars$1.81-1.1%$45.00+2,386.2%-79.4%$7.64M$12.74M0.00250 Related Companies and Tools Related Companies BIAFW Alternatives PRENW Alternatives SQLLW Alternatives STRRP Alternatives MIND Alternatives BNSO Alternatives COEP Alternatives XWEL Alternatives ATHE Alternatives OTRK Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SQL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SeqLL Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SeqLL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
